1018818-16-0

Basic information

• Product Name: (R)-3-(2-methoxymethylpyrrolidin-1-yl)-N-methoxy-N-methylpropanamide
• Synonyms: (R)-3-(2-methoxymethylpyrrolidin-1-yl)-N-methoxy-N-methylpropanamide
• CAS NO: 1018818-16-0
• Molecular Weight: 230.307
• Mol File: 1018818-16-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-3-(2-methoxymethylpyrrolidin-1-yl)-N-methoxy-N-methylpropanamide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-(2-methoxymethylpyrrolidin-1-yl)-N-methoxy-N-methylpropanamide(1018818-16-0)
• EPA Substance Registry System: (R)-3-(2-methoxymethylpyrrolidin-1-yl)-N-methoxy-N-methylpropanamide(1018818-16-0)

Safety Data

• Hazardous Substances Data: 1018818-16-0(Hazardous Substances Data)

Upstream product

• 63126-47-6 (2R)-methoxymethylpyrrolidine 
• 193634-77-4 N-methoxy-N-methylacrylamide 

Relevant articles and documents

Isoquinoline compound and pharmaceutical use thereof

The present invention relates to an isoquinoline compound represented by the following formula (I), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction. Furthermore, this compound is useful as a prophylactic and/or therapeutic agent that improves neurological symptoms associated with cerebral infarction, particularly acute cerebral infarction. wherein the symbols are the same as defined in the description.